Clene Inc. (CLNN) compared with its closest peers (LIXT, HRTX, TLPH, RNXT, SDEV). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Lixte Biotechnology Holdings, Inc. (LIXT) | $65.21M | -3.1 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| Talphera, Inc. (TLPH) | $62.02M | — |
| RenovoRx, Inc. (RNXT) | $59.31M | — |
| Stablecoin Development Corp (SDEV) | $58.21M | 0.1 |
| Context Therapeutics Inc. (CNTX) | $54.75M | -3.9 |
| Xilio Therapeutics, Inc. (XLO) | $52.68M | -0.2 |
| Impact BioMedical Inc. (IBO) | $51.75M | 65.6 |
| TransCode Therapeutics, Inc. (RNAZ) | $50.20M | -0.1 |
| Hyperion DeFi, Inc. (HYPD) | $47.90M | 14.6 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
CLNN overview · CLNN earnings · CLNN financials · CLNN KPIs · CLNN investor relations · CLNN ownership · CLNN filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.